Allison B. Goldfine
Section of Clinical Research
Joslin Diabetes Center
Boston
MA 02215
USA
Name/email consistency: high
- Modulation of β-cell function: a translational journey from the bench to the bedside. Goldfine, A.B., Kulkarni, R.N. Diabetes. Obes. Metab (2012)
- Statins and risk of new-onset diabetes mellitus. Shah, R.V., Goldfine, A.B. Circulation (2012)
- Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Halperin, F., Lopez, X., Manning, R., Kahn, C.R., Kulkarni, R.N., Goldfine, A.B. Diabetes (2012)
- Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free Fatty acids. Lopez, X., Cypess, A., Manning, R., O'Shea, S., Kulkarni, R.N., Goldfine, A.B. J. Clin. Endocrinol. Metab. (2011)
- Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Goldfine, A.B., Gerwien, R.W., Kolberg, J.A., O'Shea, S., Hamren, S., Hein, G.P., Xu, X.M., Patti, M.E. Clin. Chem. (2011)
- Therapeutic approaches to target inflammation in type 2 diabetes. Goldfine, A.B., Fonseca, V., Shoelson, S.E. Clin. Chem. (2011)
- Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes. Goldfine, A.B., Fonseca, V.A., Jones, M.R., Wang, A.C., Ford, D.M., Truitt, K.E. Horm. Metab. Res. (2010)
- The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects. Goldfine, A.B., Fonseca, V.A. Postgrad. Med (2009)
- Expansion and contraction: treating diabetes with bariatric surgery. Goldfine, A.B., Shoelson, S.E., Aguirre, V. Nat. Med. (2009)
- Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway. Goldfine, A.B. Curr. Opin. Cardiol. (2008)
- Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Goldfine, A.B., Mun, E.C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D.B., Schneider, B.E., Holst, J.J., Patti, M.E. J. Clin. Endocrinol. Metab. (2007)
- Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue. Goldfine, A.B., Crunkhorn, S., Costello, M., Gami, H., Landaker, E.J., Niinobe, M., Yoshikawa, K., Lo, D., Warren, A., Jimenez-Chillaron, J., Patti, M.E. Diabetes (2006)
- Family history of diabetes is a major determinant of endothelial function. Goldfine, A.B., Beckman, J.A., Betensky, R.A., Devlin, H., Hurley, S., Varo, N., Schonbeck, U., Patti, M.E., Creager, M.A. J. Am. Coll. Cardiol. (2006)
- Cardiology patient pages. Cardiovascular disease in the diabetic patient. Goldfine, A.B., Goldfine, H.L. Circulation (2003)
- Prevention of type 2 diabetes: are we ready?. Bouche, C., Goldfine, A.B. Minerva Med. (2003)